HealthQuartzabout 2 hours ago
Eli Lilly buys biotech startup for nearly $3 billion
1 min read
Eli Lilly is acquiring a biotech startup for nearly $3 billion to expand into autoimmune diseases. The deal adds new treatment capabilities to the pharmaceutical company's pipeline. Financial terms beyond the purchase price were not detailed.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
